|
1.0 Executive Summary
2.0 Prevalence and Socioeconomic Costs of CHF
2.1 Prevalence and Cost of CHF
2.2 CHF under the Acute Care Model: Intervention and
Reimbursement
2.3 CHF under the Disease Management Model
3.0 Home Monitoring: Emerging Service Models
3.1 Technology Review
3.2 Market Segments and Service Models
3.3 ROI Analysis
3.4 Industry Barriers and Drivers
4.0 Forecasts, Implications and Recommendations
4.1 Market Sizing
4.2 Business Model Implications
4.3 Recommendations
Appendix A: Profiles of Selected Companies
A&D Medical
Alere Medical
CareMatix
CardioNet
LifeWatch
McKesson Provider Technology
Patient Care Technology
SHL Telemedicine
ViTelNet
WebVMC |